Annual General Meeting
Arena and Convention Centre,
Liverpool
Tuesday 23rd September 2014 at 5.45pm
Chairs Report
Angela Douglas
Chairman ACGS
GeL 100K Genome Project
26th September 2014
Potential Provider Information Day
2 - for applicants to understand the
next stages in the Procurement
W/c October 6 2014
Results for Stage One ITT released
W/c October 6 2014
Stage Two ITT issued
October
Site visits
October/November
Contractual and requirements
discussions
Mid/Late November
Deadline for submitting Stage Two
ITT Application
December
Results for Stage Two ITT released
December
Final clarifications
December
Contract award
1 January 2015
Contract begins - samples to be
provided for analysis
NHS E Laboratory
Reconfiguration
The scope will include genetics/genomics
services that focus on the following specific
areas:
• Inherited disorders • Sporadic genetic disorders.
• Acquired disorders
• Stratified/Personalised or Precision
Medicine for all conditions
Specification- submission to CPAG
01 October 2014
Conduct Public consultation
October - 31
December 2014
Provider Engagement Event
October
PROCUREMENT
Preparation of OJ Notice, PQQ and contract documents
PQQs advertised and responses received
PQQ Evaluated
Invitation To Tender ITT- Published and responses
received
03 November 2015
24 March 2015
10 April 2015
05 June 2015
ITT Evaluation
26 June 2015
Finalise Evaluation
03 July 2015
Winners confirmed
06 July 2015
Standstill
Contract Award
Submission Of Contract Award Notice to OJEU
20 August 2015
Conditions precedent
NHS E Laboratory
Reconfiguration 2
• ACGS is committed to supporting the
laboratories through this
• We have organised three Heads of Labs
meetings to date and have another
planned for October.
• The ACGS is keen to support and assist in
that where possible both in disseminating
and providing information.
Kevin Ocraft - RIP
•
•
•
•
•
•
•
It is with regret I note the death of Kevin Ocraft, past
Treasurer of the ACC and ACGS.
Kevin passed away suddenly and unexpectedly.
Kevin was a Cytogeneticist at Tameside Manchester, St
Mary’s Manchester, Christie Hospital and Nottingham,
he will have at some time worked with many of you
certainly worked with Kevin for a while at Christie
Hospital and I knew him for more than 25 years.
Kevin was a supportive, kind and thoughtful individual
who always behaved with the highest standard of
professionalism and I for one will not forget him.
Kevin took on the role of Treasurer of the ACC several
years ago and remained as the Treasurer for the
ACGS, both roles he undertook methodically,
thoroughly and with extreme proficiency, for which all
the previous Executive Team of the ACC and current
Executive of the ACGS will be forever grateful.
A travel fund has been established in remembrance of
him
Treasurers Report
David Cockburn
Complications during past year
• Merging finances from ACC and CMGS
• New Treasurer
•
•
arrangements for bank access setup
Slower expenses payments
Summary of current financial
position
Account balances September 2014
The Association For Clinical Cytogenetics
Business Current Account (11371967)
7th Sep 2014
£8,829.00
Business Money Manager Account (11371975)
7th Sep 2014
£60,844.82
Community Account (44660331)
3rd Sep 2014
£24,354.47
Business Money Manager Account (34660358)
3rd Sep 2014
£50,021.49
Total assets
£144,049.78
The Association For Clinical Genetics Science
Detailed Report of Accounts not yet ready
To be circulated at soonest opportunity [email]
Auditors
Audit of previous accounts
ACC (year 2013) - Report from Wilkins Kennedy
LLP approving accounts dated 1st April 2014
Members need to vote to approve auditors
for following year.
Proposal that Wilkins Kennedy are
continued as auditors for ACGS for further
year – Needs Proposer and Seconder
Subcommittee
Reports
Quality Committee
•
Best Practice Guidelines
–
–
–
–
•
Audits
–
–
–
•
NGS BPG workshop with UKGTN
General Genetic Reporting workshop
GenUs
–
•
Reviewed and changes being recommended.
Workshops
–
–
•
ACGS activity audit 2013-14 to include all activity of genetics laboratories
Working day/calendar day TAT audit
Fragile X syndrome/array testing audit
Genetics Dashboard
–
•
New pipeline for reviewing and initiating new guidelines
Completed – NGS/Fragile X syndrome
Currently under review - Lynch syndrome/AML/ALL/CML
New guidelines - General Genetic Reporting/Sarcoma by RT-PCR/Arrays/
Internal Quality Control/Hypertrophic cardiomyopathies
Review of cytogenetic bandings and changes implemented – ongoing
MRC-Holland MLPA probe incident
–
Reported to MHRA and worked with them to ensure the Dutch authorities activated follow up
Communications Committee
•
Election results
–
–
–
–
•
New members of subcommittee
–
•
–
–
–
Website training for Simon McCullough, Gareth Masson, Peter Logan and Jenny Barrett took place on
10th April. Now have 4 webmasters able to upload content.
Migration of content from ACC website to ACGS website is complete
ACC website will close 28th November 2014
Migration of content from CMGS website continues
Newsletter
–
–
–
•
Gareth Masson from Birmingham and Peter Logan from Belfast
Website
–
•
Treasurer – David Cockburn from Leeds elected 2014-2017
Secretary – Simon McCullough from Belfast elected 2014-2017
Communications subcommittee – Hazel Dinning from Nottingham elected 2014-2017
No nominations for Chair Elect – call for nominations to be sent again
Two editions published on-line
Please send articles to Martin Schwarz (martin.schwarz@nhs.net) and Emma Huxley
(emma.huxley@bwhct.nhs.net)
Deadline for next edition is 30th November 2104
Future work
–
–
–
Questionnaire on ACGS membership for non-members
Lab roadshow
STEM presentation
Scientific Committee
• ACGS Spring Meeting
– Austin Court, Birmingham, May 2014
– 2 packed-days: Germline and Cancer
– Co-organised with MolPath working group of
Association Clinical Pathologists
– Sold-out; very good feedback
– Many thanks to the Scientific Pgm Committee
• Maggie Williams, Simon Williams, Susanna Akiki, Carolyn Tysoe, Ed Atack,
Ingrid Simonic, Rachel Butler, Sandi Deans, Newton Wong, Emma Huxley
– 2015: focussed Study Days given ESHG 2015
Scientific Committee
BSGM 2014
• Scientific Pgm Committee
– Dom McMullan (Chair), Maggie Williams, Ingrid
Simonic
• Variant Interpretation Workshop
– Debs Morrogh, Carolyn Tisoe
Scientific Committee
• Data-sharing
– DECIPHER NHS consortium option
– NHS variant sharing without need for consent
– 4 centres set-up so far (CNV and SNV)
– Contact Dom McMullan for more information
• Planned specific data-collations
– Incidental DMD deletions in unaffected patients
– Incidental Ca risk variants
– FH mutations
• IMAGINE Study (PI Lucy Raymond)
– Longitudinal outcome study for patients with common CNV
disorders
Workforce & Education
Committee (WDC)
Training
• Alison Taylor-Beadling designated as the Lead Training Officer for
the ACGS, ensuring there is good communication between the WDC
and the network of training officers.
• A Training Officer day has been organised for the 13th October in
Birmingham.
• FRCPath Part 2 written options training day took place at GOSH on
5th Sept. Alison finalising facilitators for a Part 2 self-help day either
in Birmingham or GOSH.
• Organising a GT Training day either in Manchester or Birmingham.
• The WDC will be looking at additional training for GT’s.
WDC - Assessments
• The WDC is completed assessment
arrangements for the final two cytogenetic
trainees that underwent the ACC training
programme and require a certificate of
completion.
• All new Trainees should now be STP’s
WDC - Workforce
• Submitted data to RCPath Clinical Science Workforce
Committee. Genetics had the most comprehensive
workforce data.
• WDC Will go out to labs requesting further data in near
future.
• Submitted reply to RCPath in response to Health
Education England workforce requirements, June 2014.
• Submitted comments to HCPC in response to the
consultation - Standards of Proficiency for Clinical
Scientists. June 2014.
• The WDC has drafted career level descriptors for
genetics – Career Framework – Circulated for comment
WDC - Registration
• Developing the Equivalence route with the AHCS. This is now
established and open for applications.
• The AHCS establishing an accredited Register for Practitioners.
WDC is on the Academy Regulation Council for this register.
• Discussions between the VRC and similar registers and the AHCS
about establishing a cluster model for the register.
• The VRC currently has three options:
– Remain as a voluntary register
– Apply to PSA for accreditation
– Join the AHCS cluster model of assured voluntary registers and
become accredited by PSA.
• The register of Genetic Technologists is currently owned by the
professional body (ACGS). The VRC seeking support to move the
register to the AHCS. with title of Genetic Technologist retained
Any Questions
Any Other Business
Welcome the New Chair
ACGS
Dr Ann Dalton